1. Home
  2. RGP vs CGEN Comparison

RGP vs CGEN Comparison

Compare RGP & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$5.13

Market Cap

146.3M

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$1.48

Market Cap

143.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
CGEN
Founded
1996
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.3M
143.1M
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
RGP
CGEN
Price
$5.13
$1.48
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
310.6K
405.6K
Earning Date
01-07-2026
11-10-2025
Dividend Yield
5.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$534,625,000.00
$6,903,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
$231.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$1.13
52 Week High
$9.96
$2.66

Technical Indicators

Market Signals
Indicator
RGP
CGEN
Relative Strength Index (RSI) 54.11 40.30
Support Level $5.14 $1.47
Resistance Level $5.30 $1.55
Average True Range (ATR) 0.15 0.07
MACD -0.01 -0.00
Stochastic Oscillator 40.74 16.98

Price Performance

Historical Comparison
RGP
CGEN

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: